Multi-Center study on CHO-KLAT in Chinese haemophilia children

来源 :中华医学会第15次全国血栓与止血学术会议 | 被引量 : 0次 | 上传用户:a281000075
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objectives: To describe the base line of CHO-KLAT score of Chinese haemophilia children and to explore the impact factor.Methods: We recruited patients with haemophilia aged 4-18 years.Boys 7 years or older and all parents were asked to do CHO-KLAT assessment at clinic.Meanwhile we sent questionnaire to collect data including: age, residence place, social insurance situation, disease type, severity of disease, record the bleeding frequency in the past year and treatment pattern.
其他文献
目的:对1例遗传性凝血因子Ⅴ缺乏症家系进行表型与基因分析,探讨其分子发病机制.方法:对先证者及其家系成员进行凝血功能、FV活性测定进行表型诊断;用PCR法对家系成员的FV基因的25个外显子及外显子、内含子的交界区序列进行酶联反应扩增,PCR产物纯化后直接测序,与标准序列比对检测其基因突变.
会议
目的:血栓性疾病严重威胁着人类健康,近年来其遗传学病因越来越多的被报道.研究发现抑制APOC3的表达能显著降低血浆内载脂蛋白C3和甘油三酯的水平.在欧洲和非洲人群中,发现APOC3的一些突变(R19X,A43T,IVS2+1G →A,IVS3+1G→T)能降低血栓性疾病的风险.本实验目的在于研究APOC3与血栓性疾病在中国人群中的关联性.方法:本研究共对4470例中国人进行相关位点研究,包含148
会议
Background: Thrombocytopaenia is a frequent complication of liver cirrhosis, andITP is closely related with H.pylori.Several studies illuminate the associations betweenH, pylori and viral hepatitis,bu
会议
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominantly inherited vascular-malformation syndrome associated with gene mutations including ENG, ACVRL1 and SMAD4 gene.Clinically indisting
会议
We have previously reported that human umbilical cord blood-derivedstromal cells (hUCBDSCs) are able to enhance the expansion of CFU-Meg in vitro, particularly promote the megakaryocytic lineage recov
会议
Background: Chronic lymphocytic leukaemia (CLL) is generallytreated by chemoimmunotherapy, and there isan unmet medical need for noveltargeted therapies or combination therapies.Ibrutinib is an effici
会议
Background: It is widely accepted that immune complex-mediated classical complement pathwayactivation represents an important mechanism of platelet destruction in immunethrombocytopaenia (ITP) (Peersc
会议
Background: Rituximab is mostly used in patients with chronic refractory ITP who have failed multiple prior treatments, including splenectomy.Objective: The potential role of rituximab as an early the
会议
目的:评价中小剂量达那唑治疗原发免疫性血小板减少症(ITP)的长期疗效和安全性.方法:回顾性分析了2010年1月至2014年12月间,319例应用中小剂量达那唑(200~300mg/d)治疗的成人ITP患者.患者单用达那唑或联合激素治疗.观察疗效和不良反应并分析影响疗效的相关因素.结果:319例患者中,新诊断ITP患者25例,持续性或慢性ITP患者294例,中位年龄51 (16~86)岁,男女比例
会议
Objectives: Our study was designed to explore the influence of intravenous immunoglobulin (IVIG) and methylprednisolone (MP) on cytokines secreted by T lymphocyte in children ITP.Materials and methods
会议